Efficacy and safety of Sildenafil treatment in pulmonary hypertension caused by chronic obstructive pulmonary disease: A meta-analysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efficacy and safety of Sildenafil treatment in pulmonary hypertension caused by chronic obstructive pulmonary disease: A meta-analysis

Published:2020-09 Issue: Volume:257 Page:118001
ISSN:0024-3205
Container-title:Life Sciences
language:en
Short-container-title:Life Sciences

Author:

Hao Yingying,Zhu Yingwei,Mao Yimin,Xu Jingduan,He Xuegai,Huang Shenshen,Wang Min,Qiu Jiayong

Funder

Natural Science Foundation of Henan Province

Henan Provincial Medical Science and Technology Research Project

Henan Province Scientific and technological research

Publisher

Elsevier BV

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine

Reference37 articles.

1. Group III pulmonary hypertension: pulmonary hypertension associated with lung disease: epidemiology, pathophysiology, and treatments;JR;Cardiol. Clin.,2016

2. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study;Wang;Lancet,2018

3. Pulmonary hypertension in COPD;Chaouat;Eur. Respir. J.,2008

4. Prevalence, predictors, and survival in pulmonary hypertension related to end-stage chronic obstructive pulmonary disease;Andersen;J. Heart Lung Transplant.,2012

5. A consensus document for the selection of lung transplant candidates: 2014--an update from the pulmonary transplantation Council of the International Society for heart and lung transplantation;D;The Journal of heart and lung transplantation: the official publication of the International Society for Heart Transplantation,2015

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessment of exercise tolerance using cardiopulmonary exercise test in patients with chronic obstructive pulmonary disease and secondary pulmonary arterial hypertension treated with Sildenafil versus those receiving only standard-of-care;The Egyptian Journal of Bronchology;2024-07-30

2. Assessment of exercise tolerance using CPET in COPD-PH patients treated with Sildenafil versus those receiving only standard-of-care;2024-07-29

3. The Vasodilator Effect and Mechanism of 18β-glycyrrhetinic Acid on Isolated Pulmonary Artery Rings in Rats;Pharmacognosy Magazine;2024-04-19

4. Survival and response to pulmonary vasodilator therapies in patients with chronic obstructive pulmonary disease and pulmonary vascular phenotype;Respiratory Medicine;2024-04

5. Function of sildenafil on diseases other than urogenital system: An umbrella review;Frontiers in Pharmacology;2023-02-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3